IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,159 | -56.2% | 16,079 | -7.7% | 0.02% | -66.2% |
| Q3 2022 | $167,000 | -42.2% | 17,419 | +0.2% | 0.06% | -59.6% |
| Q1 2022 | $289,000 | +21.4% | 17,380 | +39.5% | 0.16% | +15.0% |
| Q4 2021 | $238,000 | -19.9% | 12,462 | +3.5% | 0.14% | -25.1% |
| Q3 2021 | $297,000 | +40.8% | 12,035 | +56.9% | 0.19% | -33.0% |
| Q2 2020 | $211,000 | -35.9% | 7,670 | -35.4% | 0.28% | +5.3% |
| Q4 2019 | $329,000 | +41.8% | 11,878 | -13.4% | 0.26% | +373.2% |
| Q1 2018 | $232,000 | – | 13,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |